Robert A. Schwartz
|
Robert A. Schwartz FRCP Edin |
|
|---|---|
 |
|
| Member of the Rutgers University Board of Trustees | |
|
Assumed office July 1, 2014 1 |
|
| Preceded by | Asha Samant |
| Personal details | |
| Born |
Robert Allen Schwartz June 30, 1947 Oakland, California, U.S. |
| Spouse(s) | Camila Krysicka Janniger (m. 1984–present) |
| Children | Edmund Janniger |
| Residence | Englewood, New Jersey |
| Alma mater |
University of California, Berkeley (BA) University of California, Berkeley School of Public Health (MPH) New York Medical College (MD) |
| Profession |
Physician Biomedical researcher University professor |
| Website | Faculty profile |
| 1. As Faculty Representative | |
Robert Allen Schwartz (born June 30, 1947) is an American dermatologist. He is professor and head of the Department of Dermatology at the Rutgers New Jersey Medical School. He is also professor of medicine, professor of pediatrics, professor of pathology and laboratory medicine and professor of preventive medicine and community health at the Rutgers New Jersey Medical School. He is best known for the co-discovery of AIDS-associated Kaposi sarcoma (KS-AIDS) and the Schwartz-Burgess Syndrome.
He earned a Bachelor of Arts in political science at the University of California, Berkeley in 1969, a Master of Public Health at the University of California, Berkeley School of Public Health in 1970, and a Doctor of Medicine at the New York Medical College in 1974, from which he graduated at the top of his class as a member of the Alpha Omega Alpha Honor Medical Society. He trained in dermatology at the University of Cincinnati and at the Roswell Park Cancer Institute. He advanced in academia, from the University of Arizona and the University of California, San Francisco, to the Rutgers New Jersey Medical School, where in 1983 he became the first permanent head of dermatology, establishing a dermatology residency program in 1984.
In 1981 Schwartz led one of the three groups that first described AIDS-associated Kaposi sarcoma (KS-AIDS). In 1978 he first described florid cutaneous papillomatosis. Schwartz is credited with the clinical description of new subtypes of Kaposi's sarcoma: telangiectatic Kaposi's sarcoma, keloidal Kaposi's sarcoma and ecchymotic Kaposi’s sarcoma. In 1981 he first described acral acanthotic anomaly (acral acanthosis nigricans). In 1980 Edmund Klein, Schwartz and associates published in Cancer one of the first effective treatments of Kaposi’s sarcoma, a type of cancer that became more frequent as the AIDS epidemic unfolded.
...
Wikipedia